Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.
Publication
, Journal Article
Abern, MR; Tsivian, M; Polascik, TJ
Published in: Curr Urol Rep
April 2012
Focal therapy for prostate cancer has been increasingly utilized with the goal of effective disease control while maximizing patient functional outcomes. The optimal patient selection criteria are not known and therefore are not standardized. This review compares the available expert panel consensus guidelines with the selection criteria utilized in recently published focal therapy trials. Because the data from focal trials are still maturing, the currently enrolling clinical trials are reviewed as well. In addition, the recent literature regarding technological advances in prostate biopsy and imaging strategies are added to the current guidelines to recommend a rationale for patient selection.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Curr Urol Rep
DOI
EISSN
1534-6285
Publication Date
April 2012
Volume
13
Issue
2
Start / End Page
160 / 169
Location
United States
Related Subject Headings
- Urology & Nephrology
- Ultrasound, High-Intensity Focused, Transrectal
- Treatment Outcome
- Survival Analysis
- Risk Assessment
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prognosis
- Practice Guidelines as Topic
Citation
APA
Chicago
ICMJE
MLA
NLM
Abern, M. R., Tsivian, M., & Polascik, T. J. (2012). Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep, 13(2), 160–169. https://doi.org/10.1007/s11934-012-0241-5
Abern, Michael R., Matvey Tsivian, and Thomas J. Polascik. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.” Curr Urol Rep 13, no. 2 (April 2012): 160–69. https://doi.org/10.1007/s11934-012-0241-5.
Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012 Apr;13(2):160–9.
Abern, Michael R., et al. “Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.” Curr Urol Rep, vol. 13, no. 2, Apr. 2012, pp. 160–69. Pubmed, doi:10.1007/s11934-012-0241-5.
Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012 Apr;13(2):160–169.
Published In
Curr Urol Rep
DOI
EISSN
1534-6285
Publication Date
April 2012
Volume
13
Issue
2
Start / End Page
160 / 169
Location
United States
Related Subject Headings
- Urology & Nephrology
- Ultrasound, High-Intensity Focused, Transrectal
- Treatment Outcome
- Survival Analysis
- Risk Assessment
- Randomized Controlled Trials as Topic
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prognosis
- Practice Guidelines as Topic